Locanabio Revenue and Competitors
Estimated Revenue & Valuation
- Locanabio's estimated annual revenue is currently $2.3M per year.
- Locanabio's estimated revenue per employee is $155,000
Employee Data
- Locanabio has 15 Employees.
- Locanabio grew their employee count by -59% last year.
Locanabio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director (former CEO) | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Business Officer & EVP, Strategy and Corporate Development | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | VP, Discovery, Research and Translation | Reveal Email/Phone |
6 | SVP, Human Resources | Reveal Email/Phone |
7 | SVP, Regulatory Affairs | Reveal Email/Phone |
8 | Director, Gene Therapy Process Development | Reveal Email/Phone |
9 | Associate Director | Reveal Email/Phone |
10 | Director, IT Business Partner G&A Systems | Reveal Email/Phone |
Locanabio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Locanabio?
We are creating a new class of precision medicines to treat a range of human genetic diseases. Locana's RNA-targeting technology platform allows us to precisely address these mutations on the level of RNA. By targeting RNA, our approach avoids the risk of off-target effects in DNA and is suited to address many diseases linked to dysfunctional processing of RNA. The wide range of potential indications is supported by the modularity of our RNA-targeting gene therapies which are composed of interchangeable components that provide exquisite control of specificity and activity. We are working hard to realize the potential of RNA-targeting gene therapy to treat a range of devastating illnesses. With world leadership in RNA biology and RNA-mediated disease and a top tier Board of Directors and panel of Scientific Advisors, we are poised to develop the next generation of genomic medicines for functional correction of disease.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-59%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 15 | -17% | N/A |
#2 | $0.5M | 15 | 0% | $16M |
#3 | $2.1M | 15 | -21% | N/A |
#4 | $1.3M | 15 | 0% | N/A |
#5 | $0.5M | 15 | 0% | $17.3M |